Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
Clinical trial NCT00665990 · COMPLETED
Trial details
- NCT number
- NCT00665990
- Sponsor
- St. Jude Children's Research Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2013-08-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.